What is drug utilization evaluation due?

Drug Utilization Evaluation (DUE): A qualitative evaluation of drug use, prescribing, and member fill patterns to determine the appropriateness of drug therapy.

What is the purpose of Mue?

Medication use evaluation (MUE) is a performance improvement tool that can be used when there is uncertainty over whether a medication will be beneficial, if a limited evidence base is available for a choice between two or more medications,21 as well as for analyzing the process of medication prescribing, preparation.

What is medication utilization evaluation?

Medication-use evaluation (MUE) is a performance improve- ment method that focuses on evaluating and improving medi- cation-use processes with the goal of optimal patient outcomes.

What is a DUR message?

Community pharmacists are encountering on-line drug utilization review (DUR) messages with increasing frequency. DUR messages are sent by third party claims processors and generated by pharmacies’ in-house computer systems.

Who is responsible for completing a drug utilization review?

Pharmacists routinely perform prospective reviews in their daily practice by assessing a prescription medications dosage and directions while reviewing patient information for possible drug interactions or duplicate therapy.

What are the types of utilization review?

Utilization review contains three types of assessments: prospective, concurrent, and retrospective.

What is the purpose of drug use evaluation?

Drug use evaluation (DUE) is a systematic approach that assesses the appropriateness, safety, and effectiveness of a medication to improve patient care.

Who does drug utilization review?

The Alberta Management Committee for Drug Utilization (AMCDU) provides oversight and governance of the ADUP.

How do you do a drug evaluation?

Steps in Conducting a Drug Use Evaluation

  1. Identify or Determine Optimal Use. An organization’s established criteria are defined to compare optimal use with actual use.
  2. Measure Actual Use.
  3. Evaluate.
  4. Intervene.
  5. Evaluate the DUR Program.
  6. Report the DUR Findings.

What is the difference between Mue and due?

1-3 Although these terms are sometimes used interchangeably, MUE may be differentiated in that it emphasizes improving patient outcomes and quality of life through assessment of clinical outcomes via a multidisciplinary approach whereas DUE and DUR generally refer to an ongoing, systematic, criteria-based, drug- or …

What is Drug Utilization Review?

Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met.

What are the two types of utilization reviews?

Utilization review contains three types of assessments: prospective, concurrent, and retrospective. A prospective review assesses the need for healthcare services before the service is performed.

Who are the drug utilization review board members?

The Nebraska Drug Utilization Review (DUR) Board consists of eight pharmacists and five physicians who are active in their respective professions. The DUR Board also includes two pharmacy students representing each school/college of pharmacy in Nebraska, and pharmacist consultants from the Nebraska Medicaid Drug Program.

What is a drug utilization review ( DUR )?

Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met.

What is the purpose of the Medicaid drug utilization review?

The Medicaid Drug Utilization Review (DUR) Program promotes patient safety through state-administered utilization management tools and systems that interface with the Centers for Medicare & Medicaid’s (CMS) Medicaid Management Information Systems (MMIS).

What is the second phase of drug utilization review?

Drug Utilization Review. The second phase (retrospective DUR) involves ongoing and periodic examination of claims data to identify patterns of fraud, abuse, gross overuse, or medically unnecessary care and implements corrective action when needed.